CONMED (CNMD) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

CONMED Revenue Highlights

Latest Revenue (Y)

$1.24B

Latest Revenue (Q)

$316.70M

Main Segment (Y)

General Surgery

Main Geography (Y)

UNITED STATES

CONMED Revenue by Period

CONMED Revenue by Year

Date	Revenue	Change
2023-12-31	$1.24B	19.06%
2022-12-31	$1.05B	3.45%
2021-12-31	$1.01B	17.18%
2020-12-31	$862.46M	-9.70%
2019-12-31	$955.10M	11.11%
2018-12-31	$859.63M	7.94%
2017-12-31	$796.39M	4.31%
2016-12-31	$763.52M	6.17%
2015-12-31	$719.17M	-2.08%
2014-12-31	$734.47M	-2.95%
2013-12-31	$756.75M	-1.35%
2012-12-31	$767.14M	5.80%
2011-12-31	$725.08M	1.59%
2010-12-31	$713.72M	2.73%
2009-12-31	$694.74M	-6.39%
2008-12-31	$742.18M	6.90%
2007-12-31	$694.29M	7.34%
2006-12-31	$646.81M	4.78%
2005-12-31	$617.30M	10.55%
2004-12-31	$558.39M	12.32%
2003-12-31	$497.13M	9.73%
2002-12-31	$453.06M	5.68%
2001-12-31	$428.72M	9.30%
2000-12-31	$392.23M	5.27%
1999-12-31	$372.60M	10.76%
1998-12-31	$336.40M	143.24%
1997-12-31	$138.30M	10.11%
1996-12-31	$125.60M	26.10%
1995-12-31	$99.60M	40.08%
1994-12-30	$71.10M	32.65%
1993-12-31	$53.60M	-

CONMED generated $1.24B in revenue during NA 2023, up 19.06% compared to the previous quarter, and up 144.80% compared to the same period a year ago.

CONMED Revenue by Quarter

Date	Revenue	Change
2024-09-30	$316.70M	-4.25%
2024-06-30	$330.75M	6.13%
2024-03-31	$311.63M	-4.71%
2023-12-31	$327.05M	7.38%
2023-09-30	$304.58M	-4.12%
2023-06-30	$317.65M	7.51%
2023-03-31	$295.47M	17.78%
2022-12-31	$250.87M	-8.80%
2022-09-30	$275.09M	-0.76%
2022-06-30	$277.19M	14.39%
2022-03-31	$242.33M	-11.55%
2021-12-31	$273.97M	10.11%
2021-09-30	$248.83M	-2.48%
2021-06-30	$255.16M	9.66%
2021-03-31	$232.68M	-7.97%
2020-12-31	$252.83M	6.30%
2020-09-30	$237.84M	50.73%
2020-06-30	$157.78M	-26.27%
2020-03-31	$214.01M	-19.20%
2019-12-31	$264.87M	13.39%
2019-09-30	$233.59M	-1.96%
2019-06-30	$238.26M	9.11%
2019-03-31	$218.38M	-9.93%
2018-12-31	$242.44M	19.84%
2018-09-30	$202.31M	-4.94%
2018-06-30	$212.82M	5.32%
2018-03-31	$202.06M	-9.21%
2017-12-31	$222.56M	17.06%
2017-09-30	$190.12M	-3.57%
2017-06-30	$197.15M	5.67%
2017-03-31	$186.57M	-8.59%
2016-12-31	$204.09M	10.45%
2016-09-30	$184.79M	-4.47%
2016-06-30	$193.43M	6.75%
2016-03-31	$181.20M	-5.14%
2015-12-31	$191.02M	12.90%
2015-09-30	$169.18M	-6.54%
2015-06-30	$181.03M	1.73%
2015-03-31	$177.94M	-8.03%
2014-12-31	$193.47M	11.43%
2014-09-30	$173.63M	-7.04%
2014-06-30	$186.78M	3.43%
2014-03-31	$180.59M	-10.56%
2013-12-31	$201.91M	13.54%
2013-09-30	$177.83M	-7.18%
2013-06-30	$191.59M	3.32%
2013-03-31	$185.43M	-7.86%
2012-12-31	$201.24M	10.64%
2012-09-30	$181.88M	-4.12%
2012-06-30	$189.69M	-2.38%
2012-03-31	$194.32M	4.71%
2011-12-31	$185.58M	7.39%
2011-09-30	$172.81M	-5.69%
2011-06-30	$183.24M	-0.12%
2011-03-31	$183.45M	-0.34%
2010-12-31	$184.08M	6.90%
2010-09-30	$172.19M	-4.91%
2010-06-30	$181.09M	2.68%
2010-03-31	$176.37M	-7.48%
2009-12-31	$190.63M	8.64%
2009-09-30	$175.47M	6.63%
2009-06-30	$164.57M	0.31%
2009-03-31	$164.06M	-8.47%
2008-12-31	$179.25M	-0.09%
2008-09-30	$179.41M	-6.92%
2008-06-30	$192.75M	1.04%
2008-03-31	$190.77M	0.64%
2007-12-31	$189.57M	-

CONMED generated $316.70M in revenue during Q3 2024, up -4.25% compared to the previous quarter, and up 99.70% compared to the same period a year ago.

CONMED Revenue Breakdown

CONMED Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22
Orthopedic Surgery	$533.16M	$461.53M
General Surgery	$711.59M	$583.94M

CONMED's latest annual revenue breakdown by segment (product or service), as of Dec 23: General Surgery (57.17%), and Orthopedic Surgery (42.83%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23	Mar 23	Sep 22	Jun 22	Mar 22	Sep 21	Jun 21	Mar 21	Sep 20	Jun 20	Mar 20	Sep 19	Jun 19	Mar 19	Sep 18	Jun 18
General Surgery	$186.16M	$192.56M	$190.52M	$179.91M	$176.86M	$164.29M	$156.47M	$157.01M	$134.81M	$143.08M	$147.27M	$125.51M	$135.65M	$97.30M	$114.73M	$123.26M	$122.51M	$104.94M	$99.38M	$102.69M
Orthopedic Surgery	$130.54M	$139.54M	$136.53M	$124.67M	$140.79M	$131.18M	$118.62M	$120.18M	$107.52M	$105.75M	$107.89M	$107.17M	$102.19M	$60.48M	$99.28M	$110.33M	$115.76M	$113.44M	$102.93M	$110.13M

CONMED's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: General Surgery (58.78%), and Orthopedic Surgery (41.22%).

CONMED Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$700.16M	$1.16B	$158.55M	$139.72M	$179.42M
Americas (excluding the United States)	$120.93M	$212.21M	$63.82M	$50.36M	$64.27M
Asia Pacific	$197.40M	$324.95M	$107.59M	$93.64M	$101.33M
EMEA	$226.25M	$395.87M	$108.46M	$91.00M	$118.30M

CONMED's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (56.25%), EMEA (18.18%), Asia Pacific (15.86%), and Americas (excluding the United States) (9.72%).

Quarterly Revenue by Country

Country	Sep 24	Jun 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Americas (excluding the United States)	$28.82M	$31.64M	$49.99M	$29.33M	$22.62M	$18.99M	$17.42M	$17.77M	$19.99M	$16.17M	$16.61M	$16.12M	$13.71M	$17.38M	$15.20M	$13.77M	$5.58M	$15.80M	$16.38M	$17.07M
EMEA	$55.52M	$63.69M	$109.11M	$51.44M	$32.58M	$33.12M	$24.69M	$26.91M	$32.06M	$29.98M	$31.13M	$24.16M	$27.12M	$26.05M	$28.27M	$23.10M	$13.71M	$25.91M	$32.10M	$24.69M
UNITED STATES	$183.15M	$185.37M	$428.35M	$170.52M	$52.34M	$48.94M	$49.08M	$45.69M	$40.46M	$37.95M	$42.69M	$37.96M	$40.78M	$37.13M	$42.38M	$38.91M	$21.39M	$37.04M	$48.30M	$42.53M
Asia Pacific	$49.21M	$51.41M	$80.75M	$53.28M	$33.25M	$30.12M	$24.02M	$28.24M	$27.67M	$23.42M	$27.19M	$27.52M	$26.28M	$26.60M	$26.90M	$26.40M	$19.80M	$20.54M	$27.02M	$26.04M

CONMED's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (57.83%), EMEA (17.53%), Asia Pacific (15.54%), and Americas (excluding the United States) (9.10%).

CONMED Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
STE	STERIS	$5.14B	$1.33B
ITGR	Integer	$1.60B	$746.27M
GMED	Globus Medical	$1.57B	$625.71M
CNMD	CONMED	$1.24B	$316.70M
LIVN	LivaNova	$1.15B	$318.11M
IRTC	iRhythm	$492.68M	$147.54M
ATEC	Alphatec	$482.26M	$47.99M
GKOS	Glaukos	$314.71M	$96.67M
ANIK	Anika Therapeutics	$166.66M	$38.75M
KIDS	OrthoPediatrics	$148.73M	$52.80M
SIBN	SI-BONE	$138.89M	$40.34M
SRDX	Surmodics	$126.08M	$30.34M
SGHT	Sight Sciences	$81.06M	$20.16M
LUNG	Pulmonx	$68.67M	$20.39M
OFIX	Orthofix Medical	$100.00K	$198.62M

CNMD Revenue FAQ

What is CONMED’s yearly revenue?

CONMED's yearly revenue for 2023 was $1.24B, representing an increase of 19.06% compared to 2022. The company's yearly revenue for 2022 was $1.05B, representing an increase of 3.45% compared to 2021. CNMD's yearly revenue for 2021 was $1.01B, representing an increase of 17.18% compared to 2020.

What is CONMED’s quarterly revenue?

CONMED's quarterly revenue for Q3 2024 was $316.7M, a -4.25% decrease from the previous quarter (Q2 2024), and a 3.98% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $330.75M, a 6.13% increase from the previous quarter (Q1 2024), and a 4.12% increase year-over-year (Q2 2023). CNMD's quarterly revenue for Q1 2024 was $311.63M, a -4.71% decrease from the previous quarter (Q4 2023), and a 5.47% increase year-over-year (Q1 2023).

What is CONMED’s revenue growth rate?

CONMED's revenue growth rate for the last 3 years (2021-2023) was 23.16%, and for the last 5 years (2019-2023) was 30.33%.

What are CONMED’s revenue streams?

CONMED's revenue streams in c 23 are Orthopedic Surgery, and General Surgery. Orthopedic Surgery generated $533.16M in revenue, accounting 42.83% of the company's total revenue, up 15.52% year-over-year. General Surgery generated $711.59M in revenue, accounting 57.17% of the company's total revenue, up 21.86% year-over-year.

What is CONMED’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of CONMED was General Surgery. This segment made a revenue of $711.59M, representing 57.17% of the company's total revenue.